Physician
Hematology
Dr. Robert G. Kilbourn, MD
|
|
Give Review
Doctor Robert G. Kilbourn, MD works in the field of Hematology. He researched medicine at University of Texas Medical School. Robert Kilbourn is a published doctor and has 59 publications published. The lastest was: 'The role of nitric oxide in interleukin-2 therapy induced hypotension.' He is registered with Medicare and accepts Medicare payments.
Publications
- A phase I study of FAP (5-Fluorouracil, ?-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignancies.
- Cationic liposome-mediated E1A gene transfer to human breast and ovarian Cancer cells and its biologic effects: a phase I clinical trial.
- Effects of N-methyl-L-arginine on cardiac and regional blood flow in a dog endotoxin shock model.
- Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine.
- Can nitric oxide proDuction be modulated by altering L-arginine levels?
- Nitric oxide synthase inhibitors--a mechanism-based treatment of septic shock.
- The role of nitric oxide in interleukin-2 therapy induced hypotension.
- Drug-induced vasodilation in an in vitro and in vivo study: the effects of nicardipine, papaverine, and lidocaine on the rabbit carotid artery.
- Design of nitric oxide synthase inhibitors and their use to reverse hypotension associated with Cancer immunotherapy.
- Nitric oxide overproDuction in septic shock--methemoglobin concentrations and blockade with diaspirin cross-linked hemoglobin.
- Nitric oxide and shock.
- Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies.
- Tetrahydrobiopterin synthesis inhibitors induce nitric oxide synthesis in rat aorta.
- Potent inhibition of inducible nitric oxide synthase by geldanamycin, a tyrosine kinase inhibitor, in endothelial, smooth muscle Cells, and in rat aorta.
- NO in septic shock: good, bad or ugly? Learning from iNOS knockouts.
- Nitric oxide: moving towards the clinic.
- Nitric oxide synthase inhibitors: amino acids.
- Changes in regional hemodynamics after nitric oxide inhibition during ovine bacteremia.
- Nitric oxide and sepsis.
- Cardiac and regional hemodynamic interactions between halothane and nitric oxide synthase activity in dogs.
- A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal Cell carcinoma.
- Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate Cancer.
- 5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder Carcinoma: an effective regimen.
- Phase II trial of low dose gamma-interferon in metastatic renal Cell carcinoma.
- NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs.
- NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
- Cell-free hemoglobin reverses the endotoxin-mediated hyporesponsivity of rat aortic rings to alpha-adrenergic agents.
- Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell Cancer.
- NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.
- Pathogenetic mechanisms of septic shock.
- Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial Tumors: re...
- Characterization of the effects of two new arginine/citrulline Analogues on constitutive and inducible nitric oxide synthases in rat aorta.
- Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies.
- S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivo.
- Cardiovascular effects of NG-methyl-L-arginine in Chronically instrumented conscious dogs.
- Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate Cancer.
- Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.
- Comparative functional Analysis of lymphocytes and monocytes from plateletapheresis.
- Activated macrophages secrete a soluble factor that inhibits mitochondrial respiration of tumor Cells.
- Mononuclear phagocyte System cytotoxins: a review.
- Rapid, quantitative microassay for the monokine respiration inhibitory factor.
- NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.
- Protease inhibitors block the macrophage-mediated inhibition of tumor Cell mitochondrial respiration.
- Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis.
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial Tumors.
- Escalated therapy for refractory urothelial Tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-...
- Endothelial Cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.
- PeriAnal ulcer in disseminated histoplasmosis.
- Role of nitric oxide in lysis of tumor Cells by cytokine-activated endothelial Cells.
- Association of germ Cell tumors and Hodgkin's disease.
- Circadian infusion of floxuridine in patients with metastatic renal Cell carcinoma.
- Regulation of nitric oxide biosynthesis: cofactor requirement and enzymatic characteristics.
- Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous Cell carcinoma of the male genital tract.
- Cytokine-activated endothelial Cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by argini...
- Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell Cancer.
- Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino...
- OverproDuction of nitric oxide in cytokine-mediated and septic shock.
- Inhibition of inducible nitric oxide synthase with inhibitors of tetrahydrobiopterin biosynthesis.
Schools
University of Texas At Houston Medical School At Houston
Duke University
MD Anderson Cancer Center
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
University of Texas MD Anderson Cancer Center -
Duke University Hospital -
University of Texas Medical School
Drug Facts
| NPI NUMBER | 1497798961 | |
| NPPES Provider LastName | KILBOURN | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 814015711 | |
| NPPES Provider State | CO | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 903.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 78.0 | |
| Percent Opioid Claims | 8.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497798961 |
| Last Name Of The Provider | KILBOURN |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Choon-Kee Lee, MD |